3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Hematologic Diseases
1
Interventions
Pemetrexed
18
Carboplatin
16
Cisplatin
14
Paclitaxel
9
Gemcitabine
7
pembrolizumab
6
Crizotinib
5
osimertinib
4
amivantamab
4
Nivolumab
4
Docetaxel
4
lazertinib
3
Vinorelbine
3
Ipilimumab
3
Afatinib
3
selpercatinib
2
lorlatinib
2
durvalumab
2
cemiplimab
2
atezolizumab
2
alectinib
2
Gefitinib
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zenocutuzumab
1
trastuzumab deruxtecan
1
trametinib
1
tepotinib
1
telisotuzumab vedotin
1
taletrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma, Non-Small-Cell Lung
×
Brentuximab Vedotin
×
Clear all
No trials found.